{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:buyer-question:rohera-healthcare-technology-private-limited-q141430485-answer-35f5405b71b185080104","key":"buyer_question:rohera-healthcare-technology-private-limited-q141430485-answer-35f5405b71b185080104","kind":"buyer_question","slug":"rohera-healthcare-technology-private-limited-q141430485-answer-35f5405b71b185080104","canonicalUrl":"https://directory.readyscan.ai/corpus/buyer-question/rohera-healthcare-technology-private-limited-q141430485-answer-35f5405b71b185080104","machineUrl":"https://directory.readyscan.ai/discovery/corpus/buyer-question/rohera-healthcare-technology-private-limited-q141430485-answer-35f5405b71b185080104.json","datePublished":"2026-10-21","dateModified":"2026-10-21","materialFingerprint":"fnv1a64:ce3cdd54ba3f1598","membershipFingerprint":"fnv1a64:ba63797b3c7c7b8f","relatedEntitySlugs":["rohera-healthcare-technology-private-limited-q141430485"],"relatedSurfaceKeys":["buyer_question:rohera-healthcare-technology-private-limited-q141430485-answer-44d922d314b96c535b98","buyer_question:rohera-healthcare-technology-private-limited-q141430485-answer-5d6a2f35108f613b43bf","buyer_question:rohera-healthcare-technology-private-limited-q141430485-answer-ba96085c19398b46e07b","evidence:rohera-healthcare-technology-private-limited-q141430485"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"rohera-healthcare-technology-private-limited-q141430485-content-6f6218cbf01137af-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q141430485","sourceRevisionId":"Q141430485:content:764b0fa93bf4e140","sourceContentHash":"fnv1a64:194285013179a8e5","recordRevisionId":"Q141430485:content:764b0fa93bf4e140","recordContentHash":"fnv1a64:4785b6403ab6b174","sourceCanonicalUrl":"https://emedica.in/","sourceModifiedAt":"2026-10-21T12:04:17.967Z","observedOn":"2026-10-21","permission":{"basis":"public_information","evidenceUrl":"https://emedica.in/"},"attributionUrl":"https://emedica.in/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"What conditions does eMedica support as adjuvant therapy?","summary":"Cited source answers across 1 active corpus record.","question":"What conditions does eMedica support as adjuvant therapy?","answers":[{"entitySlug":"rohera-healthcare-technology-private-limited-q141430485","entityName":"Rohera Healthcare & Technology Private Limited","answer":"“eMedica has been studied as adjuvant therapy across multiple chronic-care, rehabilitation, and recovery protocols including diabetes support, cardiovascular conditions, neurological disorders, pain management, respiratory conditions, kidney conditions, and cancer support — across 37 institutions in India with 4,651+ patients.”","sourceUrls":["https://emedica.in/"]}]}